Industry Insight: MedComms 6th May
Industry Insights: MedComms This week’s insights highlight topics in the medical publishing industry that we think are helpful for ongoing professional development. AMA Manual of Style, 11th Edition: Continuous updates The AMA Manual of Style, 11th edition, is an essential resource for those involved with scientific writing and publishing. However, were you aware that the […]
Industry Insight: MedComms 18th April
In this week’s insights, we highlight topics such as Committee of Medical Journal Editors (ICMJE) recommendations, LATITUDES network provides tools for use in evidence synthesis, how would you respond to an inadvertent submission to a predatory journal, and The power of raw and honest storytelling in MedComms Updated International Committee of Medical Journal Editors (ICMJE) […]
Industry Insight: MedComms 25th March
In this piece, we highlight topics in the medical publishing industry that we think are helpful for ongoing professional development. Is ChatGPT making scientists hyper-productive, journals fighting back against questionable images, and advancing clinical data transformation. Is ChatGPT making scientists hyper-productive? The highs and lows of using AI This article by Nature discusses the benefits […]
Industry Insight: MedComms 28 February
In this piece, we highlight topics in the medical publishing industry that we think are helpful for ongoing professional development. All ongoing clinical trials in the European Union must transition to the Clinical Trials Information System by 31 January 2025 The European Medicines Agency has released a reminder that there is less than a year […]
Industry Insight: MedComms 10 February
In this piece, we highlight three topics in the medical publishing industry that are sparking discussions. We focus on the updated International Committee of Medical Journal Editors recommendations and the Accurate Consensus Reporting Document (ACCORD) reporting guidelines. We also take a look at an article on the state of pharmaceutical events and meetings in 2024. […]
Industry Insights: MedComms 15 January
In this piece, we highlight two topics in the medical publishing industry that are sparking discussions. This piece focuses on disinformation and misinformation, as these have been discussed as being some of the top risks in medical writing in 2024. The Food and Drug Administration (FDA) commissioner has urged the clinical community to redouble efforts […]
Industry Insights: MedComms 7 December
In this piece, we highlight three topics in the medical publishing industry that are sparking discussions. We consider the ethical use of AI in medical publishing, followed by recommendations for using AI in scholarly communication. We also explore the involvement of patients as stakeholders in medical research. As the world embraces the advancing role of […]
Industry Insights: MedComms 13 November
Here we highlight three topics in publishing currently sparking discussions within the industry. We explore issues related to non-native English speakers in science, delve into the debate of using AI or knowledge experts in medical writing, and discuss the impact altmetrics (Alternative Metrics) might have on addressing the gender bias that disadvantages women in STEM. […]
Industry Insights: MedComms 24 October
In this piece, we spotlight three issues in the publishing world that are driving conversations within the industry. We look at inaccurate author disclosures in medical publishing, delve into the open access debate, and discuss the art of crafting suitable lay titles for clinical trials. The problem of unreliable author disclosures persists in the medical […]
Industry Insights: MedComms 2 October
Here we cover three hot topics in publishing that are shaping the industry dialogue. We focus on BioGPT: a generative AI model that generates fluent descriptions for biomedical terms, why there is a call to reform the current scholarly publishing model, and using the patient voice in publishing. As generative AI models like BioGPT and […]
Industry Insights: MedComms 18 September
With the ongoing pressure in the academic world to publish, the term ‘Publish or Perish’ is well known. Here we cover three important and related topics in the industry. We look at the use of embellished language (hyperbolic adjectives) in scientific writing, and publishing in predatory as well as open access (OA) journals. In recent […]
Industry Insights: MedComms 4th of September
Here we examine three hot topics in medical writing that are shaping the industry dialogue. We take a look at the impact of retracted scientific articles, the advantages of using artificial intelligence (AI) in text creation, and the ban by Nature on the use of AI-generated visual content in its journals. There is increasing concern […]
